Publications by authors named "Niletys Dafne Disotuar Ruiz"
Eur Thyroid J
August 2018
Article Synopsis
- The study aimed to evaluate the effectiveness of a low dose of 131-I in achieving complete response in patients with low-risk differentiated thyroid cancer (LRDTC) based on the 2015 American Thyroid Association guidelines.
- A multicenter study was conducted with 108 patients who underwent surgery and received low-dose radioiodine treatment, analyzing various factors like age, tumor size, and preablation serum thyroglobulin to predict outcomes.
- The results showed that 79.6% of patients achieved complete response, with tumor size and anti-thyroglobulin antibodies being significant predictors, while low-dose 131-I was deemed effective for LRDTC treatment within 6-12 months.
